Tuttiquotidiani e completamente gratuito. Ogni giorno aggreghiamo notizie da oltre 100 testate e generiamo sintesi AI originali per te. Aiutaci a mantenere il servizio attivo con una piccola donazione, oppure diventa TQ Pro da solo 1€/mese.

Fai una donazione TQ Pro - 1€/mese
  1. Home

Alzheimer’s drugs ‘make no meaningful difference to patients,’ major study claims

  • Posted on April 16, 2026
  • By The Independent
  • 0 Views
Alzheimer’s drugs ‘make no meaningful difference to patients,’ major study claims
Alzheimer’s drugs ‘make no meaningful difference to patients,’ major study claims

Two anti-amyloid drugs – lecanemab and donanemab – are licensed for use in the UK
continue reading...

Author
The Independent

You May Also Like